“Leaving The Ivory Tower – From Lab To Wall Street”, 10/22, University Of Montana – Missoula

University of Montana alumnus Rahul Jasuja will speak at UM on Monday, Oct. 22, about his work doing research and consulting for investment firms.

His presentation, “Leaving the Ivory Tower – From Lab to Wall Street,” will be held from 4:10 to 5 p.m. in Skaggs Building Room 117 and is free and open to the public.

Jasuja is managing director of life sciences research at MDB Capital Group http://www.mdb.com/ , a biotechnology firm based in Santa Monica, Calif. He will talk about applied aspects of microbiology and biochemistry, including what it takes to be successful in converting basic research ideas into commercial applications.

Jasuja received a master’s degree in integrative microbiology and biochemistry at UM and went on to earn a doctorate in immunology from Tufts University. He has taught and supervised medical and dental students in the field of immunology at Tufts Medical School and did postdoctoral work at Harvard Medical School.

“Given that I am at the crossroads of biomedical academic research and the capital markets, I think my presentation will add an interesting dimension and new outlook for many scientists, teachers, researchers, administrators and students,” Jasuja said.

For further information contact Julia Horn, 406-243-2646, [email protected].

http://news.umt.edu/index.asp?sec=1&too=100&eve=8&dat=10/17/2007&npa=1856

Mr. Jasuja joined MDB Capital Group in 2004 to lead its life sciences research effort, bringing both a medical background as well as extensive institutional equity research experience. Prior to joining MDB Capital Group, Mr. Jasuja served as Senior Biotechnology Research Analyst SOMA Partners LLC (formerly Techvest, LLC) and Sagient Research Systems. His past experience includes positions as Senior Biotechnology Research Analyst for the New York investment banking firm of Rodman & Renshaw. He has conducted equity research, due-diligence and consulting for institutional investors in a wide range of areas in molecular medicine, including immunotherapy, autoimmunity/inflammation, metabolic diseases, oncology, cardiology, ophthalmology, regenerative medicine and tissue engineering. Mr. Jasuja received his scientific training in immunology at Tufts Medical School and Harvard Medical School. He has conducted research in the areas of cell signaling, cancer biology, T-lymphocyte adhesion and activation, and macrophage arachidonic acid metabolism. At Tufts Medical School, he taught and supervised medical and dental students in the field of immunology. Mr. Jasuja received his B.Sc. from St. Xavier’s College, Bombay (India), his M.S. in Microbiology & Molecular Biology from the University of Montana and his Ph.D. in Immunology from Tufts Medical School in Boston.